United States - English - NLM (National Library of Medicine)

pinnacle biologics, inc. - porfimer sodium (unii: y3834sik5f) (porfimer - unii:m15h03k69b) - porfimer sodium 75 mg in 31.8 ml - photofrin ® is indicated for the palliation of patients with completely obstructing esophageal cancer, or of patients with partially obstructing esophageal cancer who, in the opinion of their healthcare provider, cannot be satisfactorily treated with nd:yag laser therapy. photofrin is indicated for the treatment of microinvasive endobronchial non-small-cell lung cancer (nsclc) in patients for whom surgery and radiotherapy are not indicated. photofrin is indicated for the reduction of obstruction and palliation of symptoms in patients with completely or partially obstructing endobronchial nsclc. photofrin is indicated for the ablation of high-grade dysplasia in barrett’s esophagus patients who do not undergo esophagectomy. - photofrin is contraindicated in patients with porphyria. - photodynamic therapy (pdt) is contraindicated in patients with an existing tracheoesophageal or bronchoesophageal fistula. - pdt is contraindicated in patients with tumors eroding into a major blood vessel. - pdt is

United States - English - NLM (National Library of Medicine)

axcan scandipharm inc. - porfimer sodium (unii: y3834sik5f) (porfimer - unii:m15h03k69b) - injection, powder, for solution - 2.5 mg in 1 ml - photodynamic therapy with photofrin® is indicated for: - palliation of patients with completely obstructing esophageal cancer, or of patients with partially obstructing esophageal cancer who, in the opinion of their physician, cannot be satisfactorily treated with nd:yag laser therapy. - reduction of obstruction and palliation of symptoms in patients with completely or partially obstructing endobronchial non-small-cell lung cancer (nsclc). - treatment of microinvasive endobronchial nsclc in patients for whom surgery and radiotherapy are not indicated. - ablation of high-grade dysplasia in barrett’s esophagus patients who do not undergo esophagectomy. photofrin® is contraindicated in patients with porphyria or in patients with known allergies to porphyrins. photodynamic therapy is contraindicated in patients with an existing tracheoesophageal or bronchoesophageal fistula. photodynamic therapy is contraindicated in patients with tumors eroding into a major blood vessel. photodynamic therapy is not

European Union - English - EMA (European Medicines Agency)

pinnacle biologics b.v.  - porfimer sodium - barrett esophagus - antineoplastic agents - photodynamic therapy (pdt) with photobarr is indicated for: ablation of high-grade dysplasia (hgd) in patients with barrett's oesophagus (bo)

Canada - English - Health Canada

concordia laboratories inc - porfimer sodium - powder for solution - 75mg - porfimer sodium 75mg - antineoplastic agents

Canada - English - Health Canada

concordia laboratories inc - porfimer sodium - powder for solution - 15mg - porfimer sodium 15mg - antineoplastic agents

Ireland - English - HPRA (Health Products Regulatory Authority)

axcan pharma international b.v. - porfimer sodium - pdr for soln for injection - 2.5 mg/ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

axcan pharma inc - porfimer sodium - powder for solution for injection - 15mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pinnacle biologics bv - porfimer sodium - powder for solution for injection - 75mg

Ireland - English - HPRA (Health Products Regulatory Authority)

axcan pharma international b.v. - porfimer sodium - pdr for soln for injection - 2.5 mg/ml